NeuroMetrix, Inc. to Present at the Canaccord Adams Diabetes & Obesity Conference

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that Dr. Shai N. Gozani, Chief Executive Officer and President, will be presenting at the Canaccord Adams Diabetes & Obesity Conference on Tuesday, May 12, 2009 at the InterContinental Barclay Hotel in New York.
MORE ON THIS TOPIC